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The human naive pluripotent stem cell (PSC) state,
corresponding to a pre-implantation stage of devel-
opment, has been difficult to capture and sustain
in vitro. We report that the Hippo pathway effector
YAP is nuclearly localized in the inner cell mass of
human blastocysts. Overexpression of YAP in human
embryonic stem cells (ESCs) and induced PSCs
(iPSCs) promotes the generation of naive PSCs.
Lysophosphatidic acid (LPA) can partially substitute
for YAP to generate transgene-free human naive
PSCs. YAP- or LPA-induced naive PSCs have a rapid
clonal growth rate, a normal karyotype, the ability to
form teratomas, transcriptional similarities to human
pre-implantation embryos, reduced heterochromatin
levels, and other hallmarks of the naive state. YAP/
LPA act in part by suppressing differentiation-
inducing effects of GSK3 inhibition. CRISPR/Cas9-
generated YAP/ cells have an impaired ability to
form colonies in naive but not primed conditions.
These results uncover an unexpected role for YAP
in the human naive state, with implications for early
human embryology.
INTRODUCTION
Human pluripotent stem cells (PSCs), including embryonic stem
cells (ESCs) and induced pluripotent stem cells (iPSCs), can be
propagated almost indefinitely and can give rise to all cell types
of the body (Takahashi and Yamanaka, 2006; Takahashi et al.,
2007; Thomson et al., 1998; Yu et al., 2007). Because of theseCellproperties, humanPSCs are an excellent system to study cellular
differentiation in normal and diseased states, with potential far-
reaching implications in regenerative medicine. Unlike mouse
ESCs (Evans and Kaufman, 1981; Martin, 1981), which are iso-
lated from the inner cellmass (ICM)of blastocysts andcanbepre-
served in vitro in a naive ICM-like state, human ESCs and iPSCs
are in a so-called ‘‘primed’’ pluripotent state that resembles the
post-implantation epiblast (Nichols andSmith, 2009). The deriva-
tion and characterization of human naive PSCs is of significant in-
terest for the following reasons: (1) they are expected to have an
elevated growth rate and efficient clonal growth from single cells,
relative to human primed PSCs; (2) this higher ease of culture is
anticipated to facilitate genome engineering using homologous
recombination, transcription activator-like effector nucleases
(TALENs), or clustered regularly interspaced short palindromic
repeat (CRISPR) approaches (Hsu et al., 2014); and (3) naive
PSCs provide an opportunity to dissect the regulation of other-
wise inaccessible stages of human embryology.
It has been suggested that the ability to maintain mouse cells in
a naive state may be possible because mouse blastocysts can
enter a dormant state called diapause, where development is
suspended for days to weeks while the uterine environment is un-
favorable (Nichols et al., 2009). Given that human embryos do not
undergo diapause, it remained unclear whether the transcriptional
circuitry to sustain the naive state is present in human cells. How-
ever, as early as 2009, several groups reported conditions that al-
lowed thederivationof humancells in alternative pluripotent states
withsomefeaturesof themousenaivestate,although thecells car-
ried transgenes and could not be maintained long term (Buecker
et al., 2010; Hanna et al., 2010; Li et al., 2009). Subsequently,
different panels of growth factors and small molecules that could
promote maintenance of transgene-free human naive-like PSCs
were described (Chan et al., 2013; Gafni et al., 2013; Ware et al.,
2014).Thesemethodswereoftennotstraightforward to implementReports 14, 2301–2312, March 15, 2016 ª2016 The Authors 2301
Figure 1. YAP Overexpression Promotes the Generation of Human Naive ESCs
(A) YAP protein is localized to the nucleus in both the trophectoderm and the ICM of human blastocysts, as shown by immunofluorescence. White, DAPI; green,
OCT4 (ICM); yellow, CDX2 (trophectoderm); red, YAP. Representative image of n = 16 human blastocysts. Scale bar, 20 mm.
(B) In naive medium N2B27+2iFL, human H9 ESCs with YAP overexpression (H9-YAP) maintain expression of the pluripotency marker AP, while control H9 cells
differentiate and do not express AP. Scale bar, 500 mm.
(C) H9-YAP cells in N2B27+2iFL have a naive-specific dome-like colony morphology and show strong positive immunostaining for pluripotency markers SSEA3,
SSEA4, TRA-1-60, TRA-1-81, OCT4, and NANOG. Black scale bar, 500 mm; white scale bar, 150 mm.
(legend continued on next page)
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in different human PSCs, and subsequent studies questioned
the extent to which the cells derived approached the naive state
(Takashima et al., 2014; Theunissen et al., 2014). Theunissen
et al. (2014) used a systematic approach to identify small mole-
cules that supportmaintenanceofnaive-likehumanESCs induced
by overexpression of NANOGand KLF2. The authors successfully
identified a combination that can induce andmaintainOCT4 distal
enhancer (DE) activity, a key criterion ofmouse naive pluripotency,
even in the absence of transgene induction.However, these trans-
gene-free cells havea slowgrowth rate, and their long-termkaryo-
typic stability was not assessed. Takashima et al. (2014) also used
overexpression of NANOG and KLF2 to trigger the transcriptional
circuitry of naive pluripotency in human cells, and they observed
thatoptimal cell growth requires transgene induction.These recent
studies lend encouragement to the notion that the naive pluripo-
tent state may indeed be achieved in human cells, although it
may be less stable than in mouse cells, and they pave the way
for the identification of novel factors and culture conditions that
may contribute to stabilization of human naive PSCs.
The Hippo pathway is emerging as a major regulator of stem
cells and organ growth, and its dysfunction is common in several
types of cancer (Mo et al., 2014). We previously found that Yes-
associated protein (YAP), a signaling and transcriptional effector
that is inhibited by the Hippo pathway, is upregulated in multiple
mouse stem and progenitor cells, including ESCs (Ramalho-
Santos et al., 2002). Recent studies from our lab in human iPSCs,
including an analysis of Hippo signaling (Qin et al., 2012) and a
genome-wide RNAi screen (Qin et al., 2014), revealed that the
Hippo pathway is a barrier to reprogramming to pluripotency.
The divergent roles of the Hippo pathway in mouse versus hu-
man PSCs suggested to us that YAP may regulate human naive
pluripotency (Qin et al., 2012).
We report here that YAP overexpression in human ESCs and
iPSCs promotes the generation of naive PSCs. YAP-induced
naive PSCs (Yin-PSCs) are capable of rapid growth long term
with a stable karyotype; have a transcriptional profile, heterochro-
matin levels, and the activity of the OCT4 DE typical of the naive
state; and form teratomas containing tissues from all three germ
layers. YAP overexpression can be mimicked by supplementing
the culture medium with lysophosphatidic acid (LPA), a small
molecule inhibitor of the Hippo pathway and an activator of YAP
(Yu et al., 2012). Our data suggest that YAP and LPA contribute
tomaintenanceofnaivepluripotency inpart bysuppressingdiffer-
entiation-inducing effects of GSK3 inhibition. Moreover, YAP/
human ESCs have an impaired ability to form naive colonies.
RESULTS
YAP Overexpression in Human ESCs and iPSCs
Promotes a Naive State
Our previous work (Qin et al., 2012) raised the possibility that
YAP might regulate human naive pluripotency, but available(D) Growth curves of H9 in DF12+bFGF primedmedium, H9-YAP in DF12+bFGFp
single cells. Only H9-YAP cells in naive medium have a high proliferate rate. Erro
(E) H9-YAP cells in N2B27+2iFL have a normal female karyotype (46, XX), as eva
(F) H9-YAP cells in N2B27+2iFL are able to form teratomas comprising tissues d
(ectoderm). (c) Epithelium (endoderm). White scale bar, 200 mm; black scale bar
Celldata from mouse studies do not support such a role. In mice,
Yap has been reported to be excluded from the nucleus of ICM
cells and has been implicated in trophectoderm development
(Nishioka et al., 2009). We therefore analyzed YAP expression
in human blastocysts by single-cell qRT-PCR and immunofluo-
rescence. Interestingly, we found that YAPmRNA is upregulated
in the epiblast of the blastocyst and that YAP protein is localized
to the nucleus in both the ICM and the trophectoderm (Figures
1A, S1A, and S1B). The nuclear distribution of YAP is distinct in
these two cell populations, with a diffuse pattern in the ICM and
a more heterogeneous pattern in the trophectoderm (Figures
S1A andS1B). These data suggest that YAPmayplay an unantic-
ipated role in human naive pluripotency in vivo.
We set out to test the role of YAP in human naive pluripotency.
In our initial attempts to generate putative human naive PSCs,
we transferred regular primed H9 ESCs, routinely cultured
in DF12+bFGF, into serum-free N2B27-based medium sup-
plemented with ERK inhibitor (PD0325901), GSK3 inhibitor
(CHIR99021), Forskolin and human LIF (N2B27+2iFL). This is
essentially the 2i medium used for culture of mouse naive
PSCs (Ying et al., 2008), with the addition of the adenylyl cyclase
activator Forskolin, because both our unpublished results and
other published findings (Hanna et al., 2010) suggested that
the cyclic AMP pathway may facilitate survival of naive-like cells.
Under these culture conditions, however, H9 cells rapidly differ-
entiate and completely lose expression of the pluripotency
marker alkaline phosphatase (AP) within four passages (Fig-
ure 1B). We next investigated the ability of YAP to induce the
naive state. We generated H9 cells overexpressing YAP in
primed conditions and tested their ability to grow in the
N2B27+2iFL medium, with trypsinization to single cells at every
passage. Control empty-vector lentiviral infection has no effect
on the transition of H9 cells to naive conditions (data not shown).
Strikingly, YAP overexpression abolishes the differentiation-
inducing effect of the N2B27+2iFL medium, and the cells retain
strong expression of AP (Figure 1B). After three passages in
N2B27+2iFL, the cells begin to show an elevated clonal growth
rate, and they propagate readily in culture with a naive-specific
dome-like colony morphology for more than 70 passages (Fig-
ure 1C). Moreover, they express pluripotency markers including
SSEA3, SSEA4, TRA-1-60, TRA-1-81, OCT4, and NANOG (Fig-
ures 1C and S1C). Compared with H9 and H9-YAP cells cultured
in primed conditions, H9-YAP cells in N2B27+2iFL have drasti-
cally increased clonal growth after trypsinization to single cells
(Figure 1D), with split ratios of about 1:50 every 3 to 5 days.
These cells, which we call Yin-PSCs, maintain a stable karyo-
type (Figure 1E) and form teratomas containing tissues from all
three germ layers after injection into immune-deficient mice
(Figure 1F).
We next investigated whether Yin-PSCs can be derived using
ESC lines other than H9, which is female, or using iPSCs. A male
human ESC line (H1) and a female iPSC line derived from lungrimedmedium, andH9-YAP in N2B27+2iFL naivemedium after trypsinization to
r bars represent SD.
luated after 20 passages in naive culture conditions.
erived from all three germ layers. (a) Adipocytes (mesoderm). (b) Neural tissue
, 50 mm.
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fibroblasts (IMR-90) were used for further studies. Similar to the
procedure described earlier, we transferred H1-YAP and IMR-90
iPSC-YAP cells into the N2B27+2iFL medium and trypsinized
them to single cells at each passage. Unlike H9-YAP, however,
H1-YAP and IMR-90 iPSC-YAP cells in N2B27+2iFL differenti-
ated after several passages (data not shown). These results
indicate that different PSCs respond differently to the transition
to naive conditions and that H9 cells may be particularly capable
of making this transition. Consequently, we explored alternatives
to the N2B27+2iFL medium, which was optimized for mouse
naive PSCs. The mTeSR medium was specifically developed
for culture of human PSCs (Ludwig et al., 2006) and has been
widely used. We therefore tested mTeSR as the base me-
dium, instead of N2B27. The mTeSR+2iFL medium allowed for
the expansion of H1-YAP and IMR-90 iPSC-YAP cells with
naive morphology and growth rates for at least passage 17
(H1-YAP) and 22 (IMR-90 iPSC-YAP) to date. Similar to
H9-YAP in N2B27+2iFL, H1-YAP and IMR-90 iPSC-YAP cells
grown in mTeSR+2iFL express pluripotency markers including
SSEA3, SSEA4, and TRA-1-81 (Figures S1D and S1E); have
normal karyotypes (Figures S1F and S1G); and form teratomas
containing tissues from all three germ layers (Figures S1H and
S1I). Moreover, mTeSR+2iFL medium also allows the generation
of Yin-PSCs from H9 ESCs (see Figure 3), WIBR3 female ESCs
(see Figure 4), and iPSCs derived from male BJ fibroblasts
(data not shown). Thus, YAP overexpression promotes the gen-
eration of naive PSCs frommultiple male and female human ESC
and iPSC lines.
LPA Activates YAP and Promotes Generation of
Transgene-free Human Naive PSCs
We next sought small molecules that would have effects similar
to YAP overexpression to avoid the need for transgenes in the
induction of the naive state. Toward this end, we explored
existing data on the regulation of the Hippo pathway in other
cellular contexts. The Hippo pathway kinases LATS1 and
LATS2 phosphorylate YAP and lead to its degradation by
the proteasome (Mo et al., 2014). Serum-borne LPA has
been shown to act via Ga12/13-coupled receptors to inhibit
LATS1/2, thereby leading to the activation of YAP in human
transformed cell lines (Yu et al., 2012). In agreement with these
findings, we found that adding LPA to H9 cells leads to an in-
crease in the levels of YAP (Figures 2A and 2B), although these
levels are much lower compared with lentiviral YAP overex-
pression (Figure S2A). We transferred H9 cells to mTeSR+2iFL
naive medium containing LPA and trypsinized them to single
cells at each passage. In the presence of LPA, H9 cells adopt
a domed-colony morphology similar to Yin-PSCs (Figure 2C),
express pluripotency markers (Figure 2C), maintain a stable
karyotype (Figure S2B), and are capable of giving rise to tera-
tomas containing tissues from all three germ layers (Figure 2D).
LPA-induced naive PSCs (Lin-PSCs) have an elevated expan-
sion rate, albeit lower than that of Yin-PSCs: they can be
passaged at a 1:10 split ratio every 3 to 5 days for at least
20 passages to date. We were also able to derive Lin-PSCs
from WIBR3 human ESCs (see Figure 3). In summary, trans-
gene-free human naive PSCs can be generated using LPA to
activate YAP.2304 Cell Reports 14, 2301–2312, March 15, 2016 ª2016 The AuthorYin-PSCs and Lin-PSCs Have a Naive-Associated
Transcriptional Profile Distinct from that
of Primed PSCs
We characterized the transcriptional profiles of Yin-PSCs and
Lin-PSCs and compared them to those of primed PSCs using
Illumina microarrays. We analyzed H9 ESCs, H1 ESCs, and
IMR-90 iPSCs cultured in primed (DF12+bFGF) medium;
H9-YAP, H1-YAP, and IMR-90 iPSC-YAP cells cultured in
primedmedium; H9-YAP cultured in N2B27+2iFL naivemedium;
H9-YAP, H1-YAP, and IMR-90 iPSC-YAP cells cultured in
mTeSR+2iFL naive medium; and H9 and WIBR3 cultured in
mTeSR+2iFL+LPA. Pearson correlation analysis revealed that
naive and primed PSCs represent two groups with distinct tran-
scriptional profiles (Figure 3A). Principal-component analysis
confirmed that all six naive PSCs cluster together and are sepa-
rated from the other six primed cell lines along PC1 (Figure S3A).
We next sought to identify the sets of genes that account for
the distinct profiles of naive and primed PSCs. In Yin-PSCs
and Lin-PSCs, 350 genes are upregulated with Log2 fold change
(FC) > 0.7 and p < 0.05 (Data S1). These genes are enriched
for functions in gastrulation, embryonic morphogenesis, forma-
tion of primary germ layers, and transforming growth factor b
(TGF-b) signaling (Figure S3B; Data S2). Surprisingly, genes
related to sterol and cholesterol biosynthesis are also highly en-
riched in this gene set (Figure S3B; Data S2; also see below).
Conversely, 510 genes are downregulated in naive cells (Data
S1). These genes are associated with functions in plasma mem-
brane, cell motion, and positive regulation of differentiation (Fig-
ure S3C; Data S3).
A recent study (Huang et al., 2014) documents that among
several alternate human PSCs, two studies (Takashima et al.,
2014; Theunissen et al., 2014) stand out as representing naive
cells with similarities to human pre-implantation embryos. To
directly compare the overall transcriptional profiles of Yin-
PSCs and Lin-PSCs to those two studies, we used gene set
enrichment analysis (GSEA). This analysis revealed that genes
upregulated in naive PSCs derived by the Jaenisch group (The-
unissen et al., 2014) or the Smith group (Takashima et al., 2014)
are also coordinately upregulated in Yin-PSCs and Lin-PSCs
(Figure 3B). The same pattern of similarity to the other two
studies is observed for genes downregulated in naive PSCs
(Figure S3D).
We next used qRT-PCR to assess the expression levels of
specific markers associated with naive pluripotency. We chose
to test the expression of NANOG, OCT4, and REX1, which are
typically associated with the self-renewal and pluripotency;
TFCP2L1, the knockdown of which inhibits resetting of primed
cells toward naive pluripotency (Takashima et al., 2014);
GP130, SOCS3, and TBX3, which are related to the LIF-STAT3
pathway; and HERVH, a primate-specific endogenous retrovirus
reported as a hallmark of naive-like ESCs (Wang et al., 2014). In
all three cell lines examined (H9, H1, and IMR-90 iPSCs), these
markers tend to be upregulated in naive cells relative to primed
cells (Figures 3C and S3E). The upregulation of these makers
is more consistent in mTeSR+2iFL or mTeSR+2iFL+LPA than
in N2B27+2iFL (Figure 3C), supporting our previous observation
that themTeSR basemedium is a better choice for induction and
maintenance of the human naive PSC state. Taken together,s
Figure 2. LPA Can Activate YAP and Promotes a Naive State of Pluripotency
(A) LPA increases the level of YAP in human H9 ESCs, as shown by immunofluorescence. Immunostaining was performed 2 days after adding LPA. Green, YAP;
blue, DAPI. Scale bar, 50 mm.
(B) Western blotting confirming that LPA increases YAP protein levels. Tubulin was used as loading control.
(C) H9 cells in N2B27+2iFL+LPA naive medium have a naive-specific dome-like colony morphology and show strong positive immunostaining for pluripotency
markers SSEA3, SSEA4, TRA-1-60, and TRA-1-81. Black scale bar, 500 mm; white scale bar, 150 mm.
(D) H9-YAP cells in N2B27+2iFL are able to form teratomas comprising tissues derived from all three germ layers. (a) Gut-like epithelium (endoderm). (b) Cartilage
(mesoderm). (c) Neural tissue (ectoderm). White scale bar, 200 mm; black scale bar, 50 mm.these data demonstrate that Yin-PSCs and Lin-PSCs have a
coordinately distinct transcriptional profile that is associated
with naive pluripotency.
We then compared the transcriptional profiles of naive Yin-
PSCs and Lin-PSCs and primed PSCs with those of pre-implan-
tation stages of human development (Yan et al., 2013). We used
a weighted gene co-expression network analysis (WGCNA)
(Zhang and Horvath, 2005), and a rigorous information theoretic
metric called variation of information (Meila, 2007) to measure
the distance between the co-expression networks of two cell
types. A major advantage of this information theoretic method
lies in its ability to compare the co-expression networks as a
whole without selecting a single module, which may be biased
and represent only a small portion of complex interactions.
Compared with other previously used methods (Huang et al.,
2014), our approach (described in Supplemental ExperimentalCellProcedures) captures a more global and unbiased view of
similarity between cell types. We found that transcriptionally,
Yin-PSCs and Lin-PSCs resemble human pre-implantation em-
bryos and show high similarities with the naive PSC datasets
by Takashima et al. (2014) and Theunissen et al. (2014). In
contrast, primed PSCs from all three labs exhibit larger variability
and form an outlier group with lower similarities to pre-implanta-
tion embryos (Figure 3D). Thus, treatment of human primed
PSCs with YAP or LPA resets them to a naive state similar to
human pre-implantation embryos.
We next sought to extract further biological insights from these
expression datasets. We queried the data for genes that have
high specificity of expression at the blastocyst stage and are
upregulated in naive Yin-PSCs and Lin-PSCs relative to primed
cells (Figure S3F). Similar to the previous gene ontology anal-
ysis (Figure S3B; Data S2), we found many of these genes toReports 14, 2301–2312, March 15, 2016 ª2016 The Authors 2305
Figure 3. Yin-PSCs and Lin-PSCs Have a Naive-like Transcriptional Profile Distinct from that of Primed PSCs
(A) Primed PSCs and Yin- and Lin-PSCs have distinct gene expression profiles, as shown by unsupervised hierarchical clustering. The top 1,000 genes with the
highest coefficient of variation were used to cluster samples using Pearson correlation coefficients. Six human primed PSC samples include H9, H1, IMR-90
(legend continued on next page)
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be involved in TGF-b signaling (GDF3, NODAL, FST), DNA
methylation (DNMT3L, NLRP7), and cholesterol biosynthesis
(DHCR24, DHCR7, IDI1) (Figure 3E). DNMT3L is an epigenetic
regulator previously found to be highly upregulated in naive
human PSCs (Theunissen et al., 2014). The observation that
cholesterol biosynthesis genes are highly upregulated in both
naive PSCs (Figures 3E and S3B; Data S2) and blastocysts
(Figure S3F) suggests a potential role for this pathway in the
naive state and early human development. Conversely, OTX2,
DNMT3B, B2M, HLA-A, HLA-B, HLA-H, and HLA-DOA are
strongly downregulated in naive cells (Figure 3E). OTX2 is a
pioneer transcription factor that drives the transition from the
naive to the primed state in mouse (Buecker et al., 2014) and
was previously shown to be sharply downregulated in human
naive PSCs (Theunissen et al., 2014). Downregulations of B2M
and HLA genes in naive cells has, to our knowledge, not been
previously reported and suggests that from an immunological
point of view, naive cells are more undifferentiated and less
immunogenic than primed cells (Chen et al., 2015; Drukker
et al., 2002).
Further Characterization of Naive Pluripotency in
Yin-PSCs and Lin-PSCs
In addition to having a distinct transcriptional program, naive
pluripotency is associated with unique features of the chro-
matin landscape and enhancer activity. Although X chromo-
some reactivation is a hallmark of female naive PSCs in mouse,
the available data are contradictory in human cells (Takashima
et al., 2014; Theunissen et al., 2014). We nevertheless explored
the X chromosome status by staining for histone 3 lysine 27
trimethylation, a reliable marker of X chromosome inactivation.
We found that low-passage primed female H9 ESCs or IMR-90
iPSCs already display significant levels of X chromosome reac-
tivation, precluding the use of this marker as a criterion for the
naive state (data not shown). We did find that primed IMR-90
iPSC-YAP have mosaic X inactivation and that this is lost
when the cells are converted to the naive state (data not
shown). On the whole, the existing data and our analysis sug-
gest that X chromosome reactivation may not unequivocally
distinguish the naive state from the primed state in human cells
(Takashima et al., 2014; Theunissen et al., 2014; Vallot et al.,
2015).iPSCs, H9-YAP, H1-YAP, and IMR-90 iPSC-YAP cells. Six human naive PSC sam
(H9-YAP T naive), H1-YAP in mTeSR+2iFL (H1-YAP T naive), IMR-90 iPSC-YAP
naive), and WIBR3 in mTeSR+2iFL+LPA (WIBR3 T+LPA naive). Primed cells are i
naive cells are in red.
(B) GSEA reveals that Yin-PSCs and Lin-PSCs have gene expression profiles con
plot for the gene set of Theunissen et al. (2014) upregulated in naive by Log2 FC >
(2014) upregulated in naive by Log2 FC > 2.0. Vertical black bars represent the
Theunissen et al. (2014) studies, distributed along the differential expression val
Yin-PSCs and Lin-PSCs (red, left) to upregulated in parental primed PSCs (blue,
(C) Yin-PSCs and Lin-PSCs express markers specific for naive pluripotency, as c
compared to H9 in primed medium (left panel) or H1 in primed medium (right pan
(D) Hierarchical clustering shows that naive Yin-PSCs and Lin-PSCs are similar t
2014) and to human pre-implantation embryos. In vivo states at various develop
(E) Volcano plot of significantly differentially expressed genes among the six hum
red are genes with a Log2 FC > 0.7 in naive and p < 0.05. In blue are genes with a
genes indicated.
CellHistone 3 lysine 9 trimethylation (H3K9me3) is a repressive
chromatin mark highly enriched at heterochromatin, and
H3K9me3 foci have been shown to be depleted in naive PSCs
(Takashima et al., 2014). In agreement with this finding, the
condensed H3K9me3 foci observed in primed PSCs almost
disappear in Yin-PSCs and Lin-PSCs (Figures 4A and S4A).
Western blotting confirmed a reduction in the total levels of
H3K9me3 in Yin-PSCs and Lin-PSCs (Figure 4B).
A further signature of naive pluripotency is the activation of
the endogenous DE of OCT4. In mouse, the DE drives Oct4
expression in ESCs, the ICM, and primordial germ cells (Yeom
et al., 1996), while the proximal enhancer (PE) activates Oct4
expression in primed epiblast stem cells (EpiSCs) and epiblast
cells (Tesar et al., 2007). Theunissen et al. (2014) established a
reporter for OCT4 DE activity in the human ESC line WIBR3 by
deleting the PE in an OCT4-GFP knockin allele. These OCT4-
DPE-GFP ESCs allowed the authors to identify a cocktail of
inhibitors and growth factors (termed 5i/L/A) that promotes
maintenance of naive human ESCs with OCT4-DPE activity. Us-
ing this cell line, we found that YAP overexpression dramatically
increases endogenous OCT4 DE activity in both 5i/L/A and
mTeSR+2iFL media, indicating that YAP promotes naive pluri-
potency in multiple culture conditions (Figure 4C). Taken
together, our data demonstrate that Yin-PSCs and Lin-PSCs
meet the key criteria of naive pluripotency.
YAP Regulates the Human Naive State and Acts in Part
by Modulating Wnt Signaling
We sought to gain insights into the mechanisms by which YAP
and LPA promote naive pluripotency. As mentioned earlier, H9
ESCs in the absence of YAP overexpression or LPA undergo
rapid morphological differentiation when cultured in 2i medium
(PD0325901+CHIR99021) after three passages (Figure S4B).
We asked whether only one inhibitor or the combination of
both induces differentiation. Short-term treatment of H9 cells
with PD0325901 (ERK inhibitor) or CHIR99021 (GSK3 inhibitor)
separately revealed that CHIR99021 is the major contributor to
this effect (Figure S4B). qRT-PCR shows that CHIR99021 leads
to an increase in the expression level of differentiation markers,
most notably CDX2 (trophectoderm) but also T (mesoderm),
SOX17 (endoderm), and SOX1 (ectoderm) (Figure S4C). We
found that LPA suppresses the differentiation-inducing effectsples include H9-YAP in N2B27+2iFL (H9-YAP N naive), H9-YAP in mTeSR+2iFL
cells in mTeSR+2iFL (iPSC-YAP T naive), H9 in mTeSR+2iFL+LPA (H9 T+LPA
ndicated in blue. H9-YAP in N2B27+2iFL naive medium is in pink, and all other
cordant with naive PSCs from other studies. The upper panel is the enrichment
3.0. The lower panel is the enrichment plot for the gene set of Takahashi et al.
position of genes upregulated in naive cells in the Takashima et al. (2014) or
ues for the entire transcriptome in this study, and ranked from upregulated in
right).
onfirmed by qRT-PCR. Values were normalized to GAPDH and UBB and then
el). Data are averages of triplicate PCR reactions, and error bars represent SD.
o naive cells from two other studies (Takashima et al., 2014; Theunissen et al.,
mental stages (Yan et al., 2013) are included in the clustering.
an naive PSC samples and the six human primed PSC samples. Highlighted in
Log2 FC < 0.7 and p < 0.05 in naive. See text for a description of the specific
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Figure 4. YAP Regulates the Human Naive State and Acts in Part by Modulating Wnt Signaling
(A) H3K9me3 is strongly reduced in naive H9 ESCs, as seen by immunofluorescence. Upper panel: H9 and H9-YAP in DF12+bFGF primed medium. Lower panel:
H9-YAP in N2B27+2iFL naive medium, H9-YAP in mTeSR+2iFL naive medium, and H9 in mTeSR+2iFL+LPA naive medium. Scale bar, 20 mm.
(B) Decreased total amount of H3K9me3 in Yin-PSCs and Lin-PSCs was confirmed by western blotting. Tubulin was used as loading control. Values indicate
densitometry analysis of the H3K9me3 level normalized to tubulin.
(legend continued on next page)
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of CHIR99021 and strongly downregulates SOX17 (Figure S4C),
which in addition to being an endoderm regulator, is a marker of
the primed state (Tesar et al., 2007). In agreement with previous
data in other systems (Gregorieff et al., 2015; Park et al., 2015),
YAP overexpressing cells display lower levels of active b-catenin
(Figure 4D) andWnt target genes (Figure 4E). These data suggest
that YAP promotes naive pluripotency in part by suppressing
differentiation-inducing effects of GSK3 inhibition.
Finally, we tested whether endogenous YAP regulates human
naive pluripotency in the absence of transgene induction. We
usedCRISPR/Cas9 to knockout the expression of YAP in primed
H9 ESCs. Western blotting confirmed the loss of YAP protein in
four independent mutant clones (Figure S4D) that carry frame-
shift mutations at the CRISPR/Cas9 target sites (Figure S4E).
We then compared self-renewal in standard primed medium,
our mTeSR 2iFL+LPA medium, and the 5i/L/A formulation of
Theunissen et al. (2014) but not the culture conditions from
the protocol of Takashima et al. (2014), because it requires over-
expression of NANOG and KLF2. We found that YAP is not
required for self-renewal of primed ESCs (Figure 4F). However,
the ability to form naive colonies after transfer to naive media
is impaired in YAP/ cells, most strikingly in the 5i/L/A medium
(Figure 4F) (Theunissen et al., 2014). These data lend strong sup-
port to the conclusion that YAP promotes naive pluripotency in
human cells.
DISCUSSION
We show here that YAP or its activator LPA promote the transi-
tion to the naive PSC state inmultiple human ESC and iPSC lines.
Yin-PSCs and Lin-PSCs can bemaintained long termwith robust
clonal growth and fulfill the key criteria of naive pluripotency.
YAP therefore represents an unexpected regulator of the human
naive state, with potential implications for our understanding of
early human embryology. Moreover, observations made during
the course of this work shed light on the conditions that underlie
the successful derivation and maintenance of human naive
PSCs.
First, our results indicate that different human PSCs lines
can have distinct abilities to maintain naive pluripotency: (1) in
N2B27+2iFL naive medium, Yin-PSCs can only be derived
from H9-YAP but not H1-YAP, IMR-90 iPSC-YAP, or other cell
lines (Figure 1); (2) in mTeSR+2iFL+LPA naive medium, Lin-
PSCs can be generated from H9 and WIBR3 (Figure 2), but in
the same conditions, H1 and IMR-90 iPSCs begin to differentiate
after several passages (data not shown); and (3) in 5i/L/A me-
dium, naive cells can be readily derived from H9 and WIBR3
(Theunissen et al., 2014) but not from H1 or IMR-90 iPSCs in(C) Flow cytometric analysis of the proportion of OCT4-DPE-GFP+WIBR3 cells wit
panels) media. Cells were expanded in bulk and analyzed at passage 3, in the abs
GFP+ cells in both media.
(D) YAP overexpression decreases levels of unphosphorylated (active) b-catenin
(E) YAP overexpression decreases the expression of Wnt target genes, as shown
to H9. Data are averages of triplicate PCR reactions, and error bars represent SD
(F) YAP knockout impairs the ability of ESCs to form naive colonies. H9 controls an
(primed), mTeSR+2iFL+LPA (naive), and 5i/L/A (naive, Theunissen et al., 2014) we
ROCK inhibitor. Seven days later, AP staining was performed and colony numbe
Cellour hands (data not shown). Importantly, YAP overexpression
in mTeSR-based medium can convert all PSC lines tested to
the naive state. However, in the absence of YAP overexpression
or in sub-optimal culture media, H9 and WIBR3 cells are more
easily induced to naive pluripotency compared with other cells
lines tested. In mice, it is well known that the ability to derive
ESCs is strongly dependent on the genetic strain. The 129 strain,
or hybrids thereof, yields ESCs efficiently, and this may be
related to the high incidence of spontaneous germ cell tumors
in these mice (Blair et al., 2011; Bustamante-Marı´n et al.,
2013). Some other strains, for example, non-obese diabetic
mice, are considered non-permissive for ESC derivation under
canonical culture conditions and require further modifications
of the media (Hanna et al., 2009). It will be interesting to deter-
mine whether there is a genetic or epigenetic predisposition to
achieve ICM-like naive pluripotency in different human PSCs.
Both H9 and WIBR3 are female cells, and the additional X chro-
mosome could potentially contribute factors that facilitate
maintenance of the naive state. Mouse female ESCs have both
X chromosomes active, but in human cells there does not
seem to be a strict correlation between XaXa status and naive
pluripotency (data not shown) (Takashima et al., 2014; Theunis-
sen et al., 2014; Vallot et al., 2015). Further research using a large
panel of PSCs will be needed to explore the differential propen-
sities of human primed PSCs to achieve a stable naive state.
Second, our work underscores the importance of the culture
medium formulation in the derivation of naive PSCs, including
the base medium. Yin-PSCs could not be derived in N2B27
base medium for several of the lines tested, and H9 Yin-PSCs
grown in N2B27 only partially express naive state markers (Fig-
ure 3C) and have intermediate levels of H3K9me3 (Figures 4A
and 4B). The mTeSR medium was superior in inducing the naive
state of H9 Yin-PSCs (Figures 3C, 4A, and 4B) and allowed the
derivation of Yin-PSCs from multiple ESCs and iPSCs resistant
to conversion in N2B27. Unlike N2B27, mTeSR is supplemented
with basic fibroblast growth factor (bFGF) and TGF-b. In mouse
ESCs, bFGF and TGF-b are considered critical for primed
EpiSCs but not for naive pluripotency (Blair et al., 2011). How-
ever, genes related to TGF-b signaling pathway, including
GDF3, NODAL, LEFTY2, SPP1, and CER1, are upregulated in
Yin-PSCs and Lin-PSCs (Figure S3B; Data S2). In agreement
with these findings, other groups included bFGF and TGF-b/
activin in their medium to culture human naive PSCs (Gafni
et al., 2013; Theunissen et al., 2014). Unlike the case in mice, it
appears that stable maintenance of the human naive PSC state
requires growth factors in addition to LIF, possibly including
bFGF and TGF-b. Previous studies used the mTeSR medium
but failed to derive human naive PSCs with similarities to humanh or without YAPoverexpression in 5i/L/A (upper panels) ormTeSR+2iFL (lower
ence of colony picking. YAP overexpression increases the ratio of OCT4-DPE-
, as shown by western blotting. Tubulin was used as loading control.
by qRT-PCR. Values were normalized toGAPDH and UBB and then compared
.
d four clones of CRISPR/Cas9-generated YAP/ cells cultured in DF12+bFGF
re trypsinized to single cells, counted, and plated onto MEFs in the presence of
rs were counted. Error bars represent SD. *p < 0.05; **p < 0.01; ***p < 0.001.
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pre-implantation embryos (Chan et al., 2013; Huang et al., 2014;
Ware et al., 2014). We believe that this is due to variations in me-
dia composition and the use of different small molecules; in addi-
tion, they did not use mTeSR with YAP overexpression or LPA.
Our data show that in the presence of exogenous YAP or LPA,
mTeSR supports an authentic naive transcription profile resem-
bling human pre-implantation embryos (Figure 3D). The quality
of our mTeSR+2iFL+LPA formulation for culturing naive cells is
further highlighted by its increased resilience to YAP loss
compared with 5i/L/A (Theunissen et al., 2014) (Figure 4F). LPA
may induce downstream effects, in addition to activating YAP,
such as activation of the closely related protein TAZ (Yu et al.,
2012). However, YAP overexpression induces a naive state with
a faster growth rate and in more cell lines than exposure to
LPA, likely because transgene overexpression achieves signifi-
cantly higher levels of YAP than does LPA treatment (Figure S2A
versus Figure 2B). It will be interesting to explore other methods
to induce high levels of YAP in a transgene-free manner.
Third, this work reveals that YAP is an unexpected regulator of
the human naive state. YAP overexpression in primed culture
conditions alone does not change colonymorphology, sensitivity
to trypsin (Figure 1D), expression of naive markers (Figures 3C
and S3E), or levels of H3K9me3 (Figures 4A, 4B, and S4A).
Moreover, the transcriptional profile is not significantly altered
betweenPSCs andPSC-YAPcells in primedmedium (Figure 3A).
These data suggest that YAP acts in conjunction with the modu-
lation of signaling pathways that are induced by the naive me-
dium. In support of this notion, we found that LPA suppresses dif-
ferentiation-inducing effects of GSK3 inhibition by CHIR99021
(Figures S4B and S4C). GSK3 inhibition enhances cell growth
capacity and viability of mouse naive PSCs (Ying et al., 2008).
However, we found that in human ESCs, GSK3 inhibition has a
dual effect: it promotes survival and proliferation but also induces
differentiation (Figure S4C). It has been reported that lowering the
concentration of CHIR99021 is beneficial for maintenance of
human naive pluripotency (Takashima et al., 2014; Theunissen
et al., 2014). Taken together, these results indicate that additional
modulation of signaling is required to balance the effects ofGSK3
inhibition on the naive state, and our work reveals that activa-
tion of YAP provides such balance. One effect of GSK3 inhibition
is the stabilization of b-catenin and activation of the canonical
Wnt pathway, both of which are countered by YAP overexpres-
sion (Figures 4D and 4E), in agreement with studies in other sys-
tems (Azzolin et al., 2014;Gregorieff et al., 2015;Park et al., 2015).
These results suggest that the combination of GSK3 inhibition
with YAP activation provides the appropriate balance of Wnt
signaling to sustain the naive state. Our findings parallel a report
that YAP reprograms intestinal stemcells toward regeneration by
antagonizing a differentiation-inducing effect promoted by high
levels ofWnt signaling (Gregorieff et al., 2015). Itwill be interesting
to further explore the potential interactions between YAP and
Wnt signaling in human naive PSCs. Moreover, YAP may in par-
allel cooperate with other factors downstream of 2iFL, TGF-b,
or bFGF to implement the transcriptional program of the naive
state. Lin-PSCs provide a platform to functionally dissect the
interactions between YAP and other cellular pathways, as well
as to identify other small molecules that contribute to stabilizing
the human naive state.2310 Cell Reports 14, 2301–2312, March 15, 2016 ª2016 The AuthorFinally, this work raises interesting questions regarding the
regulation of naive pluripotency in early human and mouse
embryology. In human blastocysts, YAP protein is nuclearly
localized in both the trophectoderm and the ICM (Figures 1A
and S1B). However, in mice, Yap has been reported to be
excluded from the nucleus of ICM cells and has been implicated
in trophectoderm development (Nishioka et al., 2009). These
findings could be interpreted as Yap having no role in the devel-
opment of mouse pluripotent cells. However, cytoplasmic Yap
may still contribute to the regulation of the ICM, for example,
by interacting with other pathways, including Wnt signaling
(Azzolin et al., 2014). Moreover, Yap/mice do not have implan-
tation defects, which would be indicative of abnormal trophecto-
derm development (Morin-Kensicki et al., 2006). Yap and Taz
may act redundantly, because both are present in the nucleus
and cytoplasm during early cleavage stages, and Yap/Taz dou-
ble mutant embryos arrest before the morula stage (Nishioka
et al., 2009). Thus, an alternative possibility is that YAP activation
reverts human PSCs to a pluripotent state with similarities to
cleavage-stage embryos, a possibility supported by our tran-
scriptional analysis (Figure 3D). Our findings warrant further
study of the role of the Hippo pathway in early mouse and human
development and provide a platform for chemically and geneti-
cally dissecting human naive pluripotency.
EXPERIMENTAL PROCEDURES
Culture of Human Primed PSCs
All research described here was done with the approval of the Stanford Uni-
versity Institutional Review Board—RENEW Biobank and the UCSF Human
Gamete, Embryo and Stem Cell Research Committee. H1 (P27) and H9
(P28) human ESCs were obtained from the WiCell Research Institute. WIBR3
human ESCs with OCT4-DPE-GFP reporter were provided by Dr. Rudolf
Jaenisch. Human iPSCs were generated from BJ and IMR-90 fibroblasts
(ATCC) using retroviruses (Harvard Gene Therapy Initiative) leading to the
overexpression of OCT4, SOX2, KLF4, and c-MYC as described earlier (Qin
et al., 2014). Human primed ESCs and iPSCs were cultured on irradiated
mouse embryonic fibroblasts (MEFs) in primedmedium (DF12+bFGF) consist-
ing of 80%DMEM/F12, 20% knockout serum replacement, 1 mM L-glutamax,
1% non-essential amino acids, 0.1 mM beta-mercaptoethanol, 1% penicillin-
streptomycin, and 8 ng/ml bFGF (all from Invitrogen). Cells were passagedwith
collagenase IV (Invitrogen) every 7 days. For YAP overexpression, YAP cDNA
was cloned into the lentiviral vector pGAMA downstream of an EF1a promoter
(EF1a-YAP-T2A-mCherry). Lentiviruses were produced and human PSCs
were infected as described earlier (Qin et al., 2014). YAP overexpressing cells
were trypsinized, isolated by fluorescence-activated cell sorting for mCherry-
positive cells, plated in the presence of ROCK inhibitor Y-27632 (Stemgent,
5 mM), and expanded in standard primed conditions.
Culture of Human Naive PSCs
To derive human naive PSCs, primed cells were switched to naive media
based on N2B27 or mTeSR. N2B27 medium consisted of a 1:1 mixture of
DMEM/F12 and Neurobasal medium, with 1% N2 supplement, 2% B27 sup-
plement, 1 mM L-glutamax, 0.1 mM beta-mercaptoethanol, 1x non-essential
amino acids, and 1x penicillin-streptomycin (all from Invitrogen). The mTeSR1
medium was purchased from STEMCELL. N2B27 and mTeSR base media
were supplemented with 2iFL: PD0325901 (Stemgent, 0.5 mM), CHIR99021
(Selleck Chemicals, 3 mM), Forskolin (Sigma, 10 mM) and recombinant human
LIF (EMD Millipore, 10 ng/ml). LPA (Sigma, 10 mM) was added to naive media
when indicated. The ROCK inhibitor Y-27632 (Stemgent, 5 mM) was used for
the first three passages. Human naive PSCs were maintained on irradiated
MEFs. To passage naive PSCs, cells were briefly washed with PBS, dissoci-
ated to single cells using TrypLE (Invitrogen), centrifuged in fibroblast mediums
(DMEM with 10% fetal bovine serum, 1 mM glutamax, 1x non-essential amino
acids, 1x sodium pyruvate, 1x penicillin/streptomycin, and 0.06 mM b-mer-
captoethanol, all from Invitrogen), and seeded onto irradiated MEFs in naive
medium. The 5i/L/A medium was prepared as described earlier (Theunissen
et al., 2014).
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